Expanded access allows patients outside of a clinical trial to be treated with an investigational drug if they have a life-threatening disease and have exhausted any other approved treatment options . Tekmira Pharmaceuticals Corporation says FDA will allow expanded use of TKM-Ebola . Patients can be treated with experimental drug if all other treatment options exhausted . TL;DR The U.S. Food and Drug Administration has approved a new drug, called TKM-Ebola, that is being tested in clinical trials to treat patients who have survived the deadly virus outbreak in West
Tekmira Pharmaceuticals Corporation says FDA will allow expanded use of TKM-Ebola . Patients can be treated with experimental drug if all other treatment options exhausted . TL;DR The U.S. Food and Drug Administration has approved a new drug, called TKM-Ebola, that is being tested in clinical trials to treat patients who have survived the deadly virus outbreak in West